Skip to main content
. 2019 May 31;12(3):313–321. doi: 10.1093/ckj/sfz070

FIGURE 1.

FIGURE 1

CKD G (GFR) and A (albuminuria) categories of patients enrolled in RCTs for current DKD therapies, cardiovascular SGLT2i trials, CANVAS and SONAR. Data from references [1, 2, 4, 20–23]. Data presented as mean ± SD and albuminuria data as median (IQR). The percentage of patients with eGFR <60 mL/min/1.73 m2 was 25.9, 22.7 and 9.11% in EMPA-REG, CANVAS and DECLARE, respectively. For albuminuria >300 mg/g, the percentages were 11, 7.1 and 6.8%, respectively.